2 registrations that name sodium Citrate as a study arm and are recruiting or about to, as ClinicalTrials.gov listed them on Oct 20, 2026. Read each listing for its full criteria and current status.
Kymata never assesses eligibility. Each listing names its own criteria; only its study team can say whether someone can join. Trial doses are given under the trial's monitoring and are not a schedule for anyone outside it.
Filter 2 registrations
Status
All 2 registrations
Not yet recruitingNCT06994312
The Impact of Nafamostat Mesylate on the Prognosis of Patients With Sepsis-Induced Coagulopathy Undergoing Hemofiltration
No phase
The First Hospital of Jilin University
About 282 people
Starts Jul 1, 2025 (estimated)
In plain words A study of sodium Citrate in people 18 and older, run by The First Hospital of Jilin University. It plans to enroll about 282 people and lists no sites yet.
Who it lists and where
Who the trial lists, as registered
Lists people 18 and older. Conditions: Sepsis-induced Coagulopathy (SIC).
Adults (Age ≥ 18 years);
Patients with SIC Undergoing Hemofiltration.
The exclusion criteria are on the listing.
What it tests, as registered
Nafamostat Mesylate; sodium citrate
Registered summary
In sepsis, the body is prone to coagulation system disorders, which may progress to sepsis-induced coagulopathy (SIC). When SIC is persistent and cannot be corrected, it often sequentially develops into disseminated intravascular coagulation (DIC) with multiple organ failure. Nafamostat mesylate can be used as an anticoagulant during blood purification in critically ill patients and is also used to treat SIC.Safe and effective anticoagulation is a prerequisite for the success of blood purification therapy. The full summary is on the listing.
Where, as registered
No sites listed yet.
Not yet recruitingNCT07737327
The Effect of Individual Sodium Citrate Consumption on Repeated Sprint Performance in Female Soccer Players
No phase
Hacettepe University
About 20 people
Starts Aug 20, 2026 (estimated)
In plain words A study of sodium Citrate in female participants 18 to 25, run by Hacettepe University. It plans to enroll about 20 people and lists no sites yet.
Female professional soccer players competing in the Turkish Women's Third League
Age between 18-25 years
Active training status (minimum 3 sessions per week)
Regular menstrual cycles
3 more inclusion criteria and the exclusion criteria are on the listing.
What it tests, as registered
Sodium Citrate Oral Product; Placebo
Registered summary
The aim of this research is to determine whether sodium citrate supplementation, taken at the best individual time, would improve repeated sprint performance in professional female soccer players. The main questions it aims to answer are: 1. Does sodium citrate improve sprint times, peak power, minimum power, and mean power during repeated sprints? 2. Does sodium citrate lower fatigue index (the drop in power across sprints) during repeated sprint exercise? 3. Does sodium citrate change blood bicarbonate, pH, and lactate levels before and after exercise? 4. The full summary is on the listing.